Human
epidemiology suggests genes affect alopecia areata
It has been shown that there is a higher incidence of alopecia
areata in genetically related individuals. This suggests that at
least some people are genetically predisposed to develop alopecia
areata. The triggers for the onset of alopecia areata may be environmental,
but the resistance of the alopecia areata lesion to treatment, its
persistence and regression, and its extent over the body may be
influenced by the presence and interaction of multiple genes.
Several studies suggest alopecia areata may have a genetic basis
(Colombe 1995, Van der Steen 1992). Alopecia areata with similar
times of onset or similar hair loss patterns has been reported
in monozygotic twins (identical twins) (Alsaleh 1995, Scerri
1992,
Bonjean 1968, Cole 1984, Hendren 1949, Weidman 1956, Stankler
1979) and dizygotic (non-identical) twins (Traub 1935, Anderson
1937, Bereston 1951, Barsky
1961, Wolf 1984, Insler 1989). Families with several generations
of alopecia areata affected individuals also suggest AA may be
a
genetically determined disease (Shelton 1942, Gol'dshtein 1978,
Dawn 1996, Hordinsky 1984, Valsecchi 1985, Van der Steen 1992).
Epidemiological studies provide basic evidence for involvement
of alopecia areata susceptibility genes. Numerous studies suggest
alopecia areata may be more frequently expressed in genetically
related individuals. Typically 10 to 20% and in one study up to
42% of patients with alopecia areata indicated at least one other
affected family member. In contrast, the lifetime risk of alopecia
areata expression in the general population has been suggested to
be 1.7% (Safavi 1995). Familial incidence is probably significantly
higher than reported in the studies as there is a tendency not to
discuss hair loss, particularly in previous generations where patchy
alopecia areata hair loss was sometimes mistaken for the socially
unacceptable disease, syphilis (Ormsby 1948). Even today the marked
psycho-social consequences of hair loss inhibit some individuals
from seeking diagnosis and treatment. Some may not be aware of their
hair loss if it is limited or develops in an area not immediately
visible to the individual.
A strong association has been observed between alopecia areata
and Down's syndrome. From 1000 patients and 1000 control subjects,
Du Vivier and Munro observed 60 cases of Down's syndrome individuals
with alopecia areata verses 1 control (Du Vivier 1975). Carter and
Jegasothy identified 19 cases in 214 Down's patients and the statistical
relationship is further supported in other studies (Carter 1976,
Wunderlich 1965). The genetic mutation for autoimmune polyendocrinopathy
syndrome type 1 (AIRE, autoimmune regulator gene, Finnish-German
APECED Consortium 1997) is also associated with a 29 to 37% prevalence
of alopecia areata (Betterle 1998). These studies suggest that candidate
gene loci for alopecia areata susceptibility may be present on human
Chromosome 21.
Associations of alopecia areata with other autoimmune diseases
have also been reported. Between 7% and 27% of AA affected patients
may also express a thyroid disease phenotype, including goiter
presence, myxedema and Hashimoto's thyroiditis (Cunliffe 1969,
Milgraum 1987,
Shellow 1992, Pualvilai 1994). Co-expression of vitiligo and alopecia
areata has also been reported at between 4% and 9% (Muller 1963,
Main 1975). However, the statistical significance of these disease
associations when compared to appropriate control populations
has
been disputed elsewhere (Salamon 1971, Gollnick 1992, Schallreuter
1994). Numerous case reports detail concordant presence of AA
with
other autoimmune diseases, such as diabetes and myasthenia gravis,
although the statistical significance is unknown (McElwee 1998).
This apparent asociation with other autoimmune diseases further
supports the idea that alopecia areata is also an autoimmune disease.
It may be that genes involved in one form of autoimmune disease
can also contribute to the development of other autoimmune disease
forms.
Overall then, many epidemiological studies support the notion
that alopecia areata susceptibility is determined in part by genetics,
at for a least some of those affected by the disease. Probably
genetics contributes to alopecia areata in everyone who has it,
but the contribution may be bigger and strogner in some while
for others the environment plays a bigger role.
Human
epidemiology suggests genes affect alopecia areata references
- Colombe
BW, Price VH, Khoury EL, Garovoy MR, Lou CD. HLA class II antigen
associations help to define two types of alopecia areata. J Am
Acad Dermatol. 1995 Nov;33(5 Pt 1):757-64.
- van der
Steen P, Traupe H, Happle R, Boezeman J, Strater R, Hamm H. The
genetic risk for alopecia areata in first degree relatives of
severely affected patients. An estimate. Acta Derm Venereol. 1992
Sep;72(5):373-5.
- Sharma
VK, Kumar B, Dawn G. A clinical study of childhood alopecia areata
in Chandigarh, India. Pediatr Dermatol. 1996 Sep-Oct;13(5):372-7.
- Hordinsky
MK, Hallgren H, Nelson D, Filipovich AH. Familial alopecia areata.
HLA antigens and autoantibody formation in an American family.
Arch Dermatol. 1984 Apr;120(4):464-8.
- Du Vivier
A, Munro DD. Alopecia areata, autoimmunity, and Down's syndrome.
Br Med J. 1975 Jan 25;1(5951):191-2.
- Carter
DM, Jegasothy BV. Alopecia areata and Down syndrome. Arch Dermatol.
1976 Oct;112(10):1397-9.
- Finnish-German
APECED Consortium. An autoimmune disease, APECED, caused by mutations
in a novel gene featuring two PHD-type zinc-finger domains. The
Finnish-German APECED Consortium. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal
Dystrophy. Nat Genet. 1997 Dec;17(4):399-403.
- Milgraum
SS, Mitchell AJ, Bacon GE, Rasmussen JE. Alopecia areata, endocrine
function, and autoantibodies in patients 16 years of age or younger.
J Am Acad Dermatol. 1987 Jul;17(1):57-61.
- Puavilai
S, Puavilai G, Charuwichitratana S, Sakuntabhai A, Sriprachya-Anunt
S. Prevalence of thyroid diseases in patients with alopecia areata.
Int J Dermatol. 1994 Sep;33(9):632-3.
- Schallreuter
KU, Lemke R, Brandt O, Schwartz R, Westhofen M, Montz R, Berger
J. Vitiligo and other diseases: coexistence or true association?
Hamburg study on 321 patients. Dermatology.
- McElwee
KJ, Boggess D, Olivry T, Oliver RF, Whiting D, Tobin DJ, Bystryn
JC, King LE Jr, Sundberg JP. Comparison of alopecia areata in
human and nonhuman mammalian species. Pathobiology. 1998;66(2):90-107.
- Safavi
KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd. Incidence
of alopecia areata in Olmsted County, Minnesota, 1975 through
1989. Mayo Clin Proc. 1995 Jul;70(7):628-33.
- Betterle C, Greggio NA, Volpato M. Clinical
review 93: Autoimmune polyglandular syndrome type 1. J Clin Endocrinol
Metab. 1998 Apr;83(4):1049-55.
- Valsecchi R, Vicari O, Frigeni A, Foiadelli
L, Naldi L, Cainelli T. Familial alopecia areata--genetic susceptibility
or coincidence? Acta Derm Venereol. 1985;65(2):175-7.
- Scerri L, Pace JL. Identical twins with
identical alopecia areata. J Am Acad Dermatol. 1992 Nov;27(5 Pt
1):766-7.
- Alsaleh QA, Nanda A, al-Hasawi F, el-Kashlan
M. Concurrent appearance of alopecia areata in siblings. Pediatr
Dermatol. 1995 Sep;12(3):285-6.
- Bonjean M, Prime A, Avon P. Pelade chez
deux jumeaux homozygotes (sic). Lyon Med 1968; 219: 1852-3.
- Cole GW, Herzlinger D. Alopecia universalis
in identical twins. Int J Dermatol. 1984 May;23(4):283.
- Hendren S. Identical alopecia areata in
identical twins. Arch Dermatol 1949; 60: 793-5.
- Weidman AI, Zion LS, Mamelok AE. Alopecia
areata occurring simultaneously in identical twins. Arch Dermatol
1956; 74: 424-6.
- Stankler L. Synchronous alopecia areata
in two siblings: a possible viral aetiology. Lancet 1979; 1: 1303-4.
- Traub EF. Alopecia areata and alopecia
totalis. Arch Dermatol Syph 1935; 32: 959
- Anderson NP. Alopecia areata in two sisters.
Arch Dermatol Syph 1937; 36: 871.
- Bereston ES, Robinson HN. Alopecia areata
occurring in two brothers and two sisters. Arch Dermatol Syph
1951; 64: 204-5.
- Barsky S, Gigli I. Alopecia areata in twins.
Arch Dermatol 1961; 83: 170.
- Wolf D, Wolf R. Simultaneous alopecia areata
in two siblings. J Am Acad Dermatol 1984; 11: 897-8.
- Insler MS, Helm CJ. Alopecia areata including
the cilia and eyebrows of two sisters. Ann Ophthalmol 1989; 21:
451-3.
- Shelton JM, Hollander L. Alopecia totalis
in father and daughter. Arch Dermatol Syph 1942; 46: 137-8.
- Gol'dshtein LM, Chipizhenko VA. Familial
alopecia areata. Vestn Dermatol Venerol 1978; 10: 36-8.
- Ormsby OS, Montgomery H. Diseases of the
skin, 7th Edition. London: Kimpton, 1948: 1365-75.
- Wunderlich C, Braun-Falco O. Mongolismus
und alopecia areata. Med Welt 1965; 10: 477-81.
- Cunliffe WJ, Hall R, Stevenson CJ, Weightman
D. Alopecia areata, thyroid disease and autoimmunity. Br J Dermatol
1969; 81: 877-81.
- Main RA, Robbie RB, Gray ES, Donald D,
Horne CH. Smooth muscle antibodies and alopecia areata. Br J Dermatol
1975; 92: 389-93.
- Salamon T, Musafija A, Milicevic M. Alopecia
areata and diseases of the thyroid gland. Dermatologica 1971;
142: 62-3.
- Gollinck H, Orfanos CE: Alopecia areata:
pathogenesis and clinical picture. In: Orfanos CE, Happle R, eds.
Hair and Hair Diseases. Berlin: Springer-Verlag, 1990: 529-69.
|